EQT AB has agreed to acquire Qiagen NV for around €9.6 billion ($10.8 billion), bringing an end to years of takeover speculation involving the European molecular testing company.
Our health is personal, but health risks are not. Around the world, entire populations — both human and wildlife — are facing new health challenges, all driven by the same culprit: environmental degradation.
Government efforts to overhaul its communication to stamp out misinformation, discrimination and public confusion in times of health crises remain ongoing.
